Thomas; Michael George

Patent Applications and Registrations

Patent applications and USPTO patent grants for Thomas; Michael George.The latest application filed is for "compounds".

Company Profile

2.8.7

Thomas; Michael George - Dundee GB
Thomas; Michael George - Braco GB
Thomas; Michael George - Madison WI

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
Compounds Grant 10,479,792 - Brand , et al. Nov	2019-11-19
Pyrazolo[3,4-D]pyrimidin derivative and its use for the treatment of leishmaniasis Grant 10,253,028 - Miles , et al.	2019-04-09
Imidazo[1,2-B][1,2,4]triazine derivatives as antiparasitic agents Grant 10,065,965 - Brand , et al. September 4, 2	2018-09-04
Compounds App 20180222911 - BRAND; Stephen ; et al.	2018-08-09
Imidazo[1,2-b][1,2,4]triazine Derivatives As Antiparasitic Agents App 20180141949 - BRAND; Stephen ; et al.	2018-05-24
Pyrazolo[3,4-d]pyrimidin Derivative And Its Use For The Treatment Of Leishmaniasis App 20170369496 - MILES; Timothy James ; et al.	2017-12-28
Pyrimidine derivatives as protein kinase inhibitors Grant 9,493,471 - Hollick , et al. November 15, 2	2016-11-15
Pyrimidine Derivatives As Protein Kinase Inhibitors App 20150344486 - HOLLICK; Jonathan James ; et al.	2015-12-03
Pyrimidine derivatives as protein kinase inhibitors Grant 9,133,199 - Hollick , et al. September 15, 2	2015-09-15
Pyrimidine Derivatives As Protein Kinase Inhibitors App 20140066436 - HOLLICK; Jonathan James ; et al.	2014-03-06
Pyrimidine derivatives as protein kinase inhibitors Grant 8,563,542 - Hollick , et al. October 22, 2	2013-10-22
Heterologous production of capreomycin and generation of new capreomycin derivatives through metabolic engineering Grant 8,044,186 - Thomas , et al. October 25, 2	2011-10-25
Pyrimidine Derivatives As Protein Kinase Inhibitors App 20110046093 - Hollick; Jonathan James ; et al.	2011-02-24
Heterologous Production of Capreomycin and Generation of New Capreomycin Derivatives Through Metabolic Engineering App 20090104658 - Thomas; Michael George ; et al.	2009-04-23

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.